[HTML][HTML] Butyrylcholinesterase is a potential biomarker for sudden infant death syndrome
CT Harrington, N Al Hafid, KA Waters - EBioMedicine, 2022 - thelancet.com
… pathophysiology of the Sudden Infant Death Syndrome (SIDS). Butyrylcholinesterase (BChE)
is … to evaluate BChE activity in infants and young children who had died from Sudden Infant …
is … to evaluate BChE activity in infants and young children who had died from Sudden Infant …
Is butyrylcholinesterase a potential biomarker for sudden infant death syndrome's prevention?: a pilot, retrospective, case-control study
B Solé Roqueta - 2023 - dugi-doc.udg.edu
… screening program is associated with sudden infant death syndrome. And the secondary …
PARTICIPANTS: Cases: Infants who died from sudden infant death syndrome in the last five …
PARTICIPANTS: Cases: Infants who died from sudden infant death syndrome in the last five …
[HTML][HTML] Refocusing SIDS research: Is butylcholinesterase a predictive biomarker?
E Matthews - EBioMedicine, 2022 - thelancet.com
… They also include sudden infant death syndrome a term allocated to an infant … A perspective
on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk …
on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk …
Letter to Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
J Durner - Ebiomedicine, 2022 - thelancet.com
… , The article “Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome”
was … as to whether the analyte butyrylcholinesterase is already available and why not yet. …
was … as to whether the analyte butyrylcholinesterase is already available and why not yet. …
[PDF][PDF] Letter Re: Butyrylcholinesterase is a potential biomarker for sudden infant death syndrome
CT Harrington, N Al Hafid, KA Waters - EBioMedicine, 2022 - thelancet.com
Dear Editor, Prof Durner, Thank you for highlighting the overlap of low BChE levels between
our SIDS and non-SIDS groups as one factor limiting the capacity for this measurement to …
our SIDS and non-SIDS groups as one factor limiting the capacity for this measurement to …
Identification of Decreased Butyrylcholinesterase in Sudden Infant Death Syndrome Is, at Best, a First Step Toward Preventive Screening
PL Hall, D Matern - Clinical Chemistry, 2023 - academic.oup.com
… Harrington et al. recognize the potential for inclusion of SIDS in NBS and recommend urgent
work on this potential biomarker; however, they do not provide an assessment of SIDS in …
work on this potential biomarker; however, they do not provide an assessment of SIDS in …
[HTML][HTML] … ) and acetylcholinesterase (AChE) in the human infant dorsal motor nucleus of the Vagus (DMNV), and alterations according to sudden infant death syndrome …
M Joda, KA Waters, R Machaalani - Neurobiology of Disease, 2023 - Elsevier
… the reaction (Taylor and Brown, 1999b), Acetylcholinesterase (AChE), the primary hydrolysis
enzyme that rapidly disintegrates ACh after signal transduction, and Butyrylcholinesterase (…
enzyme that rapidly disintegrates ACh after signal transduction, and Butyrylcholinesterase (…
Prenatal nicotine-exposure alters fetal autonomic activity and medullary neurotransmitter receptors: implications for sudden infant death syndrome
JR Duncan, M Garland, MM Myers… - Journal of Applied …, 2009 - journals.physiology.org
… of the sudden infant death syndrome (SIDS) two- to fivefold. Serotonergic (5-HT) abnormalities
are found, in infants … the sudden infant death syndrome (SIDS) is the sudden death of an …
are found, in infants … the sudden infant death syndrome (SIDS) is the sudden death of an …
Cholinergic Immunohistochemistry in the Brainstem, Focusing on the Dorsal Motor Nucleus of the Vagus (DMNV), and changes within Sudden Infant Death Syndrome …
M Al Deleemy - 2022 - ses.library.usyd.edu.au
Introduction: A dominating hypothesis of Sudden Infant Death Syndrome (SIDS), which is
defined as the unexpected death, usually during sleep, in seemingly healthy infants under the …
defined as the unexpected death, usually during sleep, in seemingly healthy infants under the …
Clinical Pearl: A New Potential Biomarker for Sudden Infant Death Syndrome (SIDS): Butyrylcholinesterase.
JR Hageman - Neonatology Today, 2022 - search.ebscohost.com
… who died at age 12-24 months of age of Sudden Unexplained Death of Infancy (SUDI) (1).
They found significantly lower butyrylcholinesterase levels in the blood of SIDS infants (1).” …
They found significantly lower butyrylcholinesterase levels in the blood of SIDS infants (1).” …